Albania vs Jordan: Statin use vs. average non-HDL cholesterol levels
Albania
3.6
in 2018
Jordan
3.6
in 2018
Albania rank
30th
Jordan rank
30th
Statin use vs. average non-HDL cholesterol levels over time
- Albania
- Jordan
How they compare
Albania currently reports 3.6 against 3.6 in Jordan, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Albania ahead.
Albania ranks 30th and Jordan ranks 30th of 191 countries.
Across the 4 decades both report, Albania averaged higher in 1 and Jordan in 3.
Head to head by decade
| Decade | Albania | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.8 | 3.75 | 0.05 | Albania |
| 1990s | 3.79 | 3.98 | 0.19 | Jordan |
| 2000s | 3.7 | 3.89 | 0.19 | Jordan |
| 2010s | 3.6 | 3.69 | 0.0889 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Albania or Jordan?
- Albania, at 3.6 against 3.6 in Jordan as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Albania and Jordan?
- 0, with Albania ahead.
- How many years of comparable data are there for Albania and Jordan?
- 39 years are reported by both, from 1980 to 2018.
- How do Albania and Jordan rank globally for statin use vs. average non-hdl cholesterol levels?
- Albania ranks 30th and Jordan ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.